ArticleDermatology and therapy2026

Real-World Effectiveness and Safety of Tildrakizumab in Moderate-to-Severe Psoriasis: A Multicenter Experience in the Basque Country.

Rosa Izu-Belloso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.